AR020086A1 - Nuevo receptor de angiotensina, preparacion y empleo del mismo - Google Patents

Nuevo receptor de angiotensina, preparacion y empleo del mismo

Info

Publication number
AR020086A1
AR020086A1 ARP990102666A ARP990102666A AR020086A1 AR 020086 A1 AR020086 A1 AR 020086A1 AR P990102666 A ARP990102666 A AR P990102666A AR P990102666 A ARP990102666 A AR P990102666A AR 020086 A1 AR020086 A1 AR 020086A1
Authority
AR
Argentina
Prior art keywords
preparation
procedure
angiotensin receptor
employment
same
Prior art date
Application number
ARP990102666A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR020086A1 publication Critical patent/AR020086A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Receptor de angiotensina, donde posee por lo menos una subunidad que contiene la secuencia de aminoácidos SEQ.ID NO.10; procedimiento para la preparacionde un ácido nucleico, procedimiento para la preparacion de un receptor de angiotensina, empleo deun ácido nucleico en un procedimiento para la preparacion deun receptor de angiotensina, para la preparacioon de una célula recombinante, para la preparacion de un medicamento, para un procedimiento para laidentificacion y caracterizacion de sustancias y para un procedimiento para la identificacion y caracterizacion de agonistas o antagonistas de receptores deangiotensina, procedimiento para la identificacion y caracterizacion de agonistas o antagonistas de receptores de angiotensina, medicamento y célularecombinante.
ARP990102666A 1998-06-08 1999-06-04 Nuevo receptor de angiotensina, preparacion y empleo del mismo AR020086A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19825494A DE19825494A1 (de) 1998-06-08 1998-06-08 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben

Publications (1)

Publication Number Publication Date
AR020086A1 true AR020086A1 (es) 2002-04-10

Family

ID=7870244

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102666A AR020086A1 (es) 1998-06-08 1999-06-04 Nuevo receptor de angiotensina, preparacion y empleo del mismo

Country Status (14)

Country Link
EP (1) EP1086217A2 (es)
JP (1) JP2002517237A (es)
KR (1) KR20010052703A (es)
CN (1) CN1304449A (es)
AR (1) AR020086A1 (es)
AU (1) AU4361699A (es)
BR (1) BR9912183A (es)
CA (1) CA2330229A1 (es)
DE (1) DE19825494A1 (es)
HU (1) HUP0102540A3 (es)
ID (1) ID27566A (es)
PL (1) PL345949A1 (es)
TR (1) TR200003662T2 (es)
WO (1) WO1999064585A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047289A2 (en) * 2004-10-21 2006-05-04 Medtronic, Inc. Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647239A4 (en) * 1992-06-24 1997-07-02 Univ Washington ANGIOTENSIN IV PEPTIDES, AND RECEPTOR.

Also Published As

Publication number Publication date
AU4361699A (en) 1999-12-30
DE19825494A1 (de) 1999-12-09
HUP0102540A2 (hu) 2001-10-28
CA2330229A1 (en) 1999-12-16
TR200003662T2 (tr) 2001-07-23
BR9912183A (pt) 2001-04-10
HUP0102540A3 (en) 2003-09-29
ID27566A (id) 2001-04-12
WO1999064585A3 (de) 2000-04-06
EP1086217A2 (de) 2001-03-28
CN1304449A (zh) 2001-07-18
KR20010052703A (ko) 2001-06-25
JP2002517237A (ja) 2002-06-18
PL345949A1 (en) 2002-01-14
WO1999064585A2 (de) 1999-12-16

Similar Documents

Publication Publication Date Title
BR0213132A (pt) Açao de peptìdeos tanto como agonistas receptores de glp1 quanto antagonistas receptores de glucagon e seus métodos farmacológicos de uso
PL346443A1 (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
DE69837707D1 (de) Heilmittel für kachexie
WO2002002634A3 (en) Human extracellular matrix and cell adhesion polypeptides
WO1999061471A3 (en) Human transmembrane proteins
WO2000000610A3 (en) Human signal peptide-containing proteins
WO2001012662A3 (en) Membrane associated proteins
ID26639A (id) Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya
WO2001057085A3 (en) G-protein coupled receptors
WO2001087937A3 (en) G-protein coupled receptors
WO2000026245A3 (en) Human membrane transport proteins
WO2001098323A3 (en) G-protein coupled receptors
WO1999049038A3 (en) Human calcium-binding proteins
WO2001007612A3 (en) Receptors and associated proteins
WO2000078953A3 (en) Human transport proteins
AR020086A1 (es) Nuevo receptor de angiotensina, preparacion y empleo del mismo
WO2000028032A3 (en) Human cell surface receptor proteins
WO2001072836A3 (en) G-protein coupled receptors
WO2003047526A3 (en) Cell adhesion and extracellular matrix proteins
WO2000065054A3 (en) Human membrane-associated proteins
ES2308850T3 (es) Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.
WO2001066742A3 (en) G-protein coupled receptors
WO1999021994A3 (en) Human vesicle membrane protein-like proteins
WO2002002757A3 (en) Adenylyl and guanylyl cyclases
WO2001046256A3 (en) Vesicle trafficking proteins

Legal Events

Date Code Title Description
FB Suspension of granting procedure